NAMI
RCKT icon

Nomura Asset Management International’s Rocket Pharmaceuticals RCKT Stock Holding History

Nomura Asset Management International’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$198K Hold
58,000
– – ﹤0.01% 1322
2026
Q1 		$208K Hold
58,000
– – ﹤0.01% 1225
2025
Q4 		$204K Buy
+58,000
New +$199K ﹤0.01% 1222

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Nomura Asset Management International's RCKT Position: Q2 2026 in Review

Nomura Asset Management International held its Rocket Pharmaceuticals (RCKT) position steady in Q2 2026 at 58,000 shares worth $198K. The position accounts for ﹤0.01% of the portfolio, ranked #1322.

Nomura Asset Management International first reported a position in RCKT in Q4 2025 and has held it in 3 quarters since. The position peaked at $208K in Q1 2026. 178 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Nomura Asset Management International held 58,000 shares of Rocket Pharmaceuticals worth $198K as of Q2 2026.
  • Nomura Asset Management International left its Rocket Pharmaceuticals share count unchanged in Q2 2026.
  • Rocket Pharmaceuticals made up ﹤0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #1322 holding.
  • Nomura Asset Management International first reported a position in Rocket Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Nomura Asset Management International's Rocket Pharmaceuticals position peaked at $208K in Q1 2026.
  • 178 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.